Assessment of abnormal placentation in pregnancies conceived with assisted reproductive technology

Abstract

AbstractObjectiveTo examine the association between assisted reproductive technology (ART) and abnormal placentation.MethodsThis is a retrospective cohort study querying the Healthcare Cost and Utilization Project's Nationwide Inpatient Sample. The study population included 14, 970, 064 deliveries for national estimates from January 2012 to September 2015. The exposure was 48, 240 pregnancies after ART. The main outcome measure encompassed three abnormal placentation pathologies (placenta previa [PP], placenta accreta spectrum [PAS], and vasa previa [VP]). Propensity score matching was performed to assess the exposure‐outcome association.ResultsPregnancy after ART was more likely to have a diagnosis of PAS (2.8 vs 1.0 per 1000 deliveries; adjusted odds ratio [aOR], 2.06 [95% confidence interval (CI), 1.44–2.93]), PP (24.5 vs 8.6 per 1000; aOR, 2.98 [95% CI, 2.64–3.35]), and VP (2.3 vs <0.3 per 1000; aOR, 11.3 [95% CI, 5.86–21.8]) compared with pregnancy without ART. Similarly, pregnancy after ART was associated with an increased likelihood of having multiple types of abnormal placentation, including VP with PP (aOR, 15.4 [95% CI, 6.15–38.4]) and PAS with PP (aOR, 2.80 [95% CI, 1.32–5.92]) compared with non‐ART pregnancy.ConclusionsThis national‐level analysis suggests that pregnancy after ART is associated with a significantly increased risk of abnormal placentation, including PAS, PP, and VP.